Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Daiichi Sankyo, Genuine, Inflarx, Lepu, Novartis, Novavax, Qbiotics, Sirnaomics, Veru.